Literature DB >> 23766845

A case of isolated rectal recurrence of muscle invasive bladder cancer.

Shaqil N Kassam1, Zared Aziz, Lick San Hung, Srikala S Sridhar.   

Abstract

We present the case of a 53-year-old man with a 25-pack/year smoking history and a 6-month history of gross hematuria, who presented with a pT3a, N0, M0, muscle invasive bladder cancer (MIBC). He declined neoadjuvant chemotherapy, but received post-cystectomy adjuvant chemotherapy. Six months post-adjuvant chemotherapy, he presented with abdominal pain and a large bowel obstruction, and was found to have an isolated rectal recurrence of MIBC. This case illustrates 2 important issues: (1) patients with a smoking history and symptoms of hematuria need to be carefully evaluated to rule out urothelial cancer; and (2) in patients with muscle invasive disease, local pelvic recurrence is common and close surveillance for recurrence needs to be implemented.

Entities:  

Year:  2013        PMID: 23766845      PMCID: PMC3668414          DOI: 10.5489/cuaj.1223

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


  21 in total

Review 1.  Asymptomatic microscopic hematuria in adults: summary of the AUA best practice policy recommendations.

Authors:  G D Grossfeld; J S Wolf; M S Litwan; H Hricak; C L Shuler; D C Agerter; P R Carroll
Journal:  Am Fam Physician       Date:  2001-03-15       Impact factor: 3.292

2.  Local recurrence after cystectomy alone for bladder carcinoma.

Authors:  K M Greven; J A Spera; L J Solin; T Morgan; G E Hanks
Journal:  Cancer       Date:  1992-06-01       Impact factor: 6.860

Review 3.  Annular constriction of the rectum secondary to transitional cell carcinoma of the bladder.

Authors:  P Langenstroer; A Zacharias; U Almagro; D Dewire
Journal:  Urology       Date:  1996-03       Impact factor: 2.649

4.  Metastatic pattern of bladder cancer: correlation with the characteristics of the primary tumor.

Authors:  Atul B Shinagare; Nikhil H Ramaiya; Jyothi P Jagannathan; Fiona M Fennessy; Mary-Ellen Taplin; Annick D Van den Abbeele
Journal:  AJR Am J Roentgenol       Date:  2011-01       Impact factor: 3.959

5.  Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data Advanced Bladder Cancer (ABC) Meta-analysis Collaboration.

Authors: 
Journal:  Eur Urol       Date:  2005-04-25       Impact factor: 20.096

Review 6.  Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines.

Authors:  Arnulf Stenzl; Nigel C Cowan; Maria De Santis; Markus A Kuczyk; Axel S Merseburger; Maria José Ribal; Amir Sherif; J Alfred Witjes
Journal:  Eur Urol       Date:  2011-03-23       Impact factor: 20.096

7.  Transrectal ultrasound as diagnostic tool for the detection of local recurrence following cystectomy and urinary diversion.

Authors:  J Simon; G Bartsch; L Rinnab; R E Hautmann; B G Volkmer
Journal:  Urol Int       Date:  2009-01-20       Impact factor: 2.089

8.  The predictors of local recurrence after radical cystectomy in patients with invasive bladder cancer.

Authors:  Hiroki Ide; Eiji Kikuchi; Akira Miyajima; Ken Nakagawa; Takashi Ohigashi; Jun Nakashima; Mototsugu Oya
Journal:  Jpn J Clin Oncol       Date:  2008-05       Impact factor: 3.019

9.  Neoadjuvant cisplatinum based combination chemotherapy in patients with invasive bladder cancer: a combined analysis of two Nordic studies.

Authors:  Amir Sherif; Lars Holmberg; Erkki Rintala; Oddvar Mestad; Jonas Nilsson; Sten Nilsson; Per-Uno Malmström
Journal:  Eur Urol       Date:  2004-03       Impact factor: 20.096

Review 10.  Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis.

Authors: 
Journal:  Lancet       Date:  2003-06-07       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.